The development in the study of genetic variations has given a strong push to the personalized medicine market. A new research report, “Personalized Medicine Market Analysis” by RNCOS, says that the improvement in the results of an individual’s treatment, reduced healthcare expenditure and better drug developments are boosting the demand for personalized medicine. Even at its nascent stage, the medicine has been emerging steadily as the new healthcare paradigm increasing revenues.
Research Analysis and Highlights
The report, which is spread over 70 pages, provides the detailed research and rational analysis of the current status and future scenario of personalized medicines across the globe. It also discusses the commercially available personalized medicine therapies for oncology, cardiovascular disorders and neurological disorders. An analysis of the regulatory environment and recent developments has also been included in the study to present a balanced outlook on the potentials of the global personalized medicine market.
Some of the Report’s Key Highlights are:
- Technological advancements driving personalized medicine market.
- Pharma giants focusing on personalized medicine.
- Increased funding to tap the growing market.
Some of our Related Reports are:
|
